When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
COPENHAGEN (Reuters) - Denmark has again raised its outlook for economic growth, fuelled by the expansion of the country's ...
In recent months Novo Nordisk has invested several billions of dollars to boost its manufacturing capacity—including its ...
Denmarks economic prospects are surging, with the government revising GDP growth forecasts upwards for 2024 and 2025, largely ...
On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No ...
Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark
Amid a multi-year, multibillion-dollar spending spree to scale its global manufacturing capacity, Novo Nordisk is laying down ...
Danish diabetes and obesity giant Novo Nordisk has announced plans to invest 2.9 billion Danish kroner ($410 million) to ...
In a report released today, Jo Walton from UBS maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price target of ...
The Danish economy will expand faster next year than previously estimated, boosted by exports from drugmakers including Novo ...
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
Around one fifth of Denmark's employment growth was attributed to an increase in staffing at Novo Nordisk, which currently employs some 30,000 people, according to the economy ministry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback